Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

Novel polyphenol derivative as potent DYRK1A inhibitor for the treatment of MS

June 9, 2022

BioVaxys reports progress in pan-sarbecovirus vaccine program

June 7, 2022

SA-FasL microgels induce immune acceptance of islet transplantation

May 27, 2022

Blue Water Vaccines collaborates with Instituto Butantan on universal influenza vaccine candidate

May 20, 2022

Burnet Institute and Moderna partner on novel mRNA vaccines for infectious diseases

May 18, 2022

Osivax collaborates with NIAID to combine OVX-836 with NIAID influenza vaccine candidates

May 17, 2022

Allorion Therapeutics presents TYK2 inhibitor ARTS-011 for the treatment of inflammatory disease

May 13, 2022

Rheos Medicines identifies new MALT1 inhibitors

May 12, 2022

Celsion advances PLACCINE DNA-based vaccine platform to proof-of-concept NHP studies

May 11, 2022

Dianthus closes series A financing to support development of antibody complement therapeutics

May 4, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Viva in vivo! At EHA, in vivo CAR T data continues to impress
BioWorld
Treatment with first-generation CAR T cells regularly sent patients to the intensive care unit. Now, investigators are envisioning a future where CAR T treatment...